EPO and retinopathy of prematurity: In ROP, EPO is regarded as a double-edged sword for its pro-angiogenic effect, which could be beneficial in the first phase of ROP when vaso-obliteration occurs due to hyperoxia, but is harmful in the second phase by aggravating abnormal neovascularization [103,104].